References
- Larsen PL, Tos M, Kuijpers W, van der Beek JM. The early stages of polyp formation. Laryngoscope 1992; 102: 670–7
- Norlander T, Westrin KM, Fukami M, Stierna P, Carlsöö B. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages. Laryngoscope 1996; 106: 196–203
- Wang QP, Escudier E, Roudot-Thoraval F, Abd-Al Samad I, Peynegre R, Coste A. Myofibroblast accumulation induced by transforming growth factor-[beta] is involved in the pathogenesis of nasal polyps. Laryngoscope 1997; 107: 926–31
- Sappino A, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990; 63: 144–61
- Coste A, Lefaucheur JP, Wang QP, Lesprit E, Poron F, Peynegre R, et al. Expression of the transforming growth factor β isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998; 124: 1361–6
- Norrby K. Mast cells and angiogenesis. APMIS 2002; 110: 355–71
- Berger P, Girodet PO, Begueret H, Ousova O, Perng DW, Marthan R, et al. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J 2003; 17: 2139–41
- Goldsmith AM, Bentley JK, Zhou L, Jia Y, Bitar KN, Fingar DC, et al. Transforming growth factor-beta induces airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 2006; 34: 247–54
- Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3: 507–11
- Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 1987; 237: 1333–6
- Smith CJ, Smith JC, Finn MC. The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. J Burn Care Rehabil 1987; 8: 126–31
- Ediger D, Sin BA, Heper A, Anadolu Y, Misirligil Z. Airway inflammation in nasal polyposis; immunopathological aspects of relation to asthma. Clin Exp Allergy 2005; 35: 319–26
- Park HS, Nahm DH, Park K, Suh KS, Yim HE. Immunohistochemical characterization of cellular infiltrate in nasal polyp from aspirin-sensitive asthmatic patients. Ann Allergy Asthma Immunol 1998; 81: 219–24
- Takasaka T, Kaku Y, Hozawa K. Mast cell degranulation in nasal polyps. Acta Otolaryngol Suppl 1986; 430: 39–48
- Brzezińska-Błaszczyk E, Czuwaj M, Kuna P. Histamine release from mast cells of various species induced by histamine releasing factor from human lymphocytes. Agents Actions 1987; 21: 26–31
- Levi-Schaffer F. Mast cell/fibroblast interactions in health and disease. Chem Immunol 1995; 61: 161–85
- Sasaki Y. Distribution of the degranulated and non-degranulated mast cells in nasal polyp. Acta Otolaryngol Suppl 1986; 430: 34–8
- Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003; 3: 1–6
- Tsukada T, McNutt M, Ross R, Gown AM. HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol 1987; 127: 389–402
- Gailit J, Marchese MJ, Kew RR, Gruber BL. The differentiation and function of myofibroblasts is regulated by mast cell mediators. J Invest Dermatol 2001; 117: 1113–19